Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.

Authors

Won Seog Kim
Yasuhiro Oki
Seok Jin Kim
Sang Eun Yoon
Kirit M Ardeshna
Yi Lin
Jia Ruan
Pierluigi Porcu
Jonathan E Brammer
Eric D Jacobsen
Dok Hyun Yoon
Cheolwon Suh
Felipe Suarez
John Radford
Lihua E Budde
Jin Seok Kim
Emmanuel Bachy
Hun Ju Lee
Catherine M. Bollard, George Washington University
Arnaud Jaccard
Hye Jin Kang
Shannon Inman
Maryann Murray
Katherin E Combs
Daniel Y Lee
Ranjana Advani
Kurt C Gunter
Cliona M Rooney
Helen E Heslop

Document Type

Journal Article

Publication Date

7-24-2021

Journal

Annals of Hematology

DOI

10.1007/s00277-021-04558-0

Comments

Online ahead of print

APA Citation

Kim, W., Oki, Y., Kim, S., Yoon, S., Ardeshna, K., Lin, Y., Ruan, J., Porcu, P., Brammer, J., Jacobsen, E., Yoon, D., Suh, C., Suarez, F., Radford, J., Budde, L., Kim, J., Bachy, E., Lee, H., Bollard, C. M., Jaccard, A., Kang, H., Inman, S., Murray, M., Combs, K., Lee, D., Advani, R., Gunter, K., Rooney, C., & Heslop, H. (2021). Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.. Annals of Hematology, (). http://dx.doi.org/10.1007/s00277-021-04558-0

Peer Reviewed

1